Ai LanD.KobayashiMD

PubMed

• 3 citations
  Long-term efficacy, safety, and tolerability of a subcutaneous immunoglobulin 16.5% (cutaquig®) in the treatment of patients with primary immunodeficiencies.
  Roger H Kobayashi, Jiří Litzman, Isaac Melamed, J Fernando Mandujano, Ai Lan Kobayashi, Bruce Ritchie, Bob Geng, T Prescott Atkinson, Syed Rehman, Sonja Höller, Eva Tu...> ;Clinical and Experimental Immunology. 2022 Dec 15
• Corrigendum: Clinical efficacy, safety and tolerability of a new subcutaneous immunoglobulin 16.5% (Octanorm [Cutaquig]) in the treatment of patients with primary immu...
  Roger H Kobayashi, Sudhir Gupta, Isaac Melamed, J Fernando Mandujano, Ai Lan Kobayashi, Bruce Ritchie, Bob Geng, Thomas Prescott Atkinson, Syed Rehman, Eva Turpel-Kant...> ;Frontiers in Immunology. 2022 Jan 1
• 4 citations
  Treatment of children with primary immunodeficiencies with a subcutaneous immunoglobulin 16.5% (cutaquig® [octanorm]).
  Roger H. Kobayashi, Jose Fernando Mandujano, Syed M. Rehman, Ai Lan Kobayashi, Bob Geng, Thomas Prescott Atkinson, Isaac Melamed, Eva Turpel-Kantor, Elisabeth Clodi, S...> ;Immunotherapy. 2021 May 6
• 7 citations
  Evaluation of Intravenous Immunoglobulin in Pediatric Acute-Onset Neuropsychiatric Syndrome.
  Isaac Melamed, Roger H. Kobayashi, Maeve O’Connor, Ai Lan Kobayashi, Andrew Schechterman, Melinda Heffron, Sharon Canterberry, Holly Miranda, Nazia Rashid> ;Journal of Child and Adolescent Psychopharmacology. 2021 Mar 15
• 15 citations
  Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the Treatment of Patients With Primary Immunodeficiencies
  Roger H. Kobayashi, Sudhir Gupta, Isaac Melamed, J. Fernando Mandujano, Ai Lan Kobayashi, Bruce Ritchie, Bob Geng, Thomas Prescott Atkinson, Syed M. Rehman, Eva Turpel...> ;Frontiers in Immunology. 2019 Feb 4
• 10 citations
  Intravenous immunoglobulin 10% in children with primary immunodeficiency diseases.
  Hans D. Ochs, Isaac Melamed, Michael Borte, James N. Moy, Barbara Pyringer, Ai Lan D. Kobayashi, Alan P. Knutsen, William Smits, Anna Pituch-Noworolska, Roger H. Kobay...> ;Immunotherapy. 2018 Aug 8
• 11 citations
  Efficacy and Safety of Human Intravenous Immunoglobulin 10% (Panzyga®) in Patients with Primary Immunodeficiency Diseases: a Two-Stage, Multicenter, Prospective, Open-...
  Michael Borte, Isaac Melamed, Grazyna Pulka, Barbara Pyringer, Alan P. Knutsen, Hans D. Ochs, Roger H. Kobayashi, Ai Lan Kobayashi, Sudhir Gupta, Magdalena Strach, Wil...> ;Journal of Clinical Immunology. 2017 Jul 29
• 20 citations
  Efficacy, Safety, and Pharmacokinetics of a New 10 % Liquid Intravenous Immunoglobulin Containing High Titer Neutralizing Antibody to RSV and Other Respiratory Viruses...
  Richard L. Wasserman, William R. Lumry, James B. Harris, Robyn J. Levy, Mark R. Stein, Lisa R. Forbes, Charlotte Cunningham-Rundles, Isaac Melamed, Ai Lan Kobayashi, W...> ;Journal of Clinical Immunology. 2016 Jun 20
• 23 citations
  Home self-administration of intravenous immunoglobulin therapy in children.
  Roger H. Kobayashi, AiLan D. Kobayashi, Napoleon Lee, Susanna Fischer, Hans D. Ochs> ;Pediatrics. 1990 May 1
• 301 citations
  Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase.
  Michael S. Hershfield, Rebecca H. Buckley, Michael L. Greenberg, A L Melton, Richard I. Schiff, Christine L. Hatem, Joanne Kurtzberg, M L Markert, R H Kobayashi, A L K...> ;The New England Journal of Medicine. 1987 Mar 5
• Join now to see all